Veru reports positive phase 2 clinical results of veru-111 in hospitalized covid-19 patients at high risk for acute respiratory distress syndrome

– potential for two-pronged action against covid-19 as an antiviral and anti-inflammatory agent supported by phase 2 clinical study results –

VERU Ratings Summary

VERU Quant Ranking